ABBV vs HCA
By Alex · Tickerpine
AbbVie Inc. vs HCA Healthcare, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | HCA |
|---|---|---|
| Price | $265.79 | $428.76 |
| Market cap | $469.68B | $92.83B |
| P/E ratio | 74.7 | 14.4 |
| ROE | — | — |
| Profit margin | 9.80% | 8.77% |
| Revenue growth | 10.20% | 8.70% |
| Dividend yield | 2.62% | 0.73% |
| Beta | 0.28 | 1.11 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs HCA in plain English
- ABBV is the bigger company — about 5.1× the market cap of HCA.
- HCA is cheaper on earnings (P/E 14.4 vs 74.7).
- ABBV is growing revenue faster (10% vs 9%).
- ABBV has the higher dividend yield (2.62% vs 0.73%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
HCA return calculator
See what $1,000 in HCA Healthcare, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.